Cancer heat therapy-enhancing agent
US9012502B2 · kind B2 · utility
14Cited by
0References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 12, 2011 |
| Grant date | Apr 21, 2015 |
| Priority date | — |
| Expiry date | Jan 15, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is an enhancer for cancer thermotherapy not combined with photodynamic therapy. Cancer treatment not combined with photodynamic therapy is made available by using, as an enhancer for cancer thermotherapy, 5-aminolevulinic acids represented by formula (1):R2R1NCH2COCH2CH2COR3 (1)[wherein R1 and R2 each independently represent a hydrogen atom, an alkyl group, an acyl group, an alkoxycarbonyl group, an aryl group, or an aralkyl group; and R3 represents a hydroxy group, an alkoxy group, an acyloxy group, an alkoxycarbonyloxy group, an aryloxy group, an aralkyloxy group, or an amino group] or a salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.